RT Journal Article
SR Electronic
T1 616 Pharmacokinetics and safety of a subcutaneous formulation of nivolumab (NIVO SC) monotherapy: updated results from the phase 1/2 CheckMate 8KX study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A701
OP A702
DO 10.1136/jitc-2023-SITC2023.0616
VO 11
IS Suppl 1
A1 Lonardi, Sara
A1 Ługowska, Iwona
A1 O’Donnell, Anne
A1 Jackson, Christopher
A1 Latten-Jansen, Loes Maria
A1 North, Richard
A1 Salvo, Marcelo Garrido
A1 Santoro, Armando
A1 Chacón, Matías
A1 Li, Linghui
A1 Joseph, Devanand
A1 Gibson, Elizabeth
A1 Bennett, Bryan
A1 Gurm, Balmeet
A1 Ng, Wee-Teck
A1 Donald Harvey, R
A1 Trigo Pérez, José Manuel
A1 Calvo, Aitana
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A701.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.